These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 35931928)

  • 1. Current knowledge in the use of bacteriophages to combat infections caused by Pseudomonas aeruginosa in cystic fibrosis.
    Martínez-Gallardo MJ; Villicaña C; Yocupicio-Monroy M; Alcaraz-Estrada SL; León-Félix J
    Folia Microbiol (Praha); 2023 Feb; 68(1):1-16. PubMed ID: 35931928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges and Promises for Planning Future Clinical Research Into Bacteriophage Therapy Against
    Rossitto M; Fiscarelli EV; Rosati P
    Front Microbiol; 2018; 9():775. PubMed ID: 29780361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteriophages φMR299-2 and φNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells.
    Alemayehu D; Casey PG; McAuliffe O; Guinane CM; Martin JG; Shanahan F; Coffey A; Ross RP; Hill C
    mBio; 2012; 3(2):e00029-12. PubMed ID: 22396480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo antibacterial activity of environmental bacteriophages against Pseudomonas aeruginosa strains from cystic fibrosis patients.
    Olszak T; Zarnowiec P; Kaca W; Danis-Wlodarczyk K; Augustyniak D; Drevinek P; de Soyza A; McClean S; Drulis-Kawa Z
    Appl Microbiol Biotechnol; 2015 Jul; 99(14):6021-33. PubMed ID: 25758956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacteriophage PEV20 and Ciprofloxacin Combination Treatment Enhances Removal of Pseudomonas aeruginosa Biofilm Isolated from Cystic Fibrosis and Wound Patients.
    Chang RYK; Das T; Manos J; Kutter E; Morales S; Chan HK
    AAPS J; 2019 Apr; 21(3):49. PubMed ID: 30949776
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Alipour-Khezri E; Skurnik M; Zarrini G
    Viruses; 2024 Jun; 16(7):. PubMed ID: 39066214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of Bacteriophages in Removing Biofilms of
    Fong SA; Drilling A; Morales S; Cornet ME; Woodworth BA; Fokkens WJ; Psaltis AJ; Vreugde S; Wormald PJ
    Front Cell Infect Microbiol; 2017; 7():418. PubMed ID: 29018773
    [No Abstract]   [Full Text] [Related]  

  • 8. Isolation and Characterization of Three Pseudomonas aeruginosa Viruses with Therapeutic Potential.
    Wang X; Tang J; Dang W; Xie Z; Zhang F; Hao X; Sun S; Liu X; Luo Y; Li M; Gu Y; Wang Y; Chen Q; Shen X; Xu L
    Microbiol Spectr; 2023 Jun; 11(3):e0463622. PubMed ID: 37125933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of a Broad-Range Bacteriophage Cocktail That Reduces Pseudomonas aeruginosa Biofilms and Treats Acute Infections in Two Animal Models.
    Forti F; Roach DR; Cafora M; Pasini ME; Horner DS; Fiscarelli EV; Rossitto M; Cariani L; Briani F; Debarbieux L; Ghisotti D
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29555626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vitro Newly Isolated Environmental Phage Activity against Biofilms Preformed by
    Fiscarelli EV; Rossitto M; Rosati P; Essa N; Crocetta V; Di Giulio A; Lupetti V; Di Bonaventura G; Pompilio A
    Microorganisms; 2021 Feb; 9(3):. PubMed ID: 33668889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacteriophage Delivery by Nebulization and Efficacy Against Phenotypically Diverse Pseudomonas aeruginosa from Cystic Fibrosis Patients.
    Sahota JS; Smith CM; Radhakrishnan P; Winstanley C; Goderdzishvili M; Chanishvili N; Kadioglu A; O'Callaghan C; Clokie MR
    J Aerosol Med Pulm Drug Deliv; 2015 Oct; 28(5):353-60. PubMed ID: 25714328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a new
    Whiteley LE; Whiteley M
    Microbiol Spectr; 2024 Mar; 12(3):e0371923. PubMed ID: 38345389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of bacteriophages in the sputum of cystic fibrosis patients.
    Saussereau E; Vachier I; Chiron R; Godbert B; Sermet I; Dufour N; Pirnay JP; De Vos D; Carrié F; Molinari N; Debarbieux L
    Clin Microbiol Infect; 2014 Dec; 20(12):O983-90. PubMed ID: 24920209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two Novel Bacteriophages Improve Survival in
    Jeon J; Yong D
    Appl Environ Microbiol; 2019 May; 85(9):. PubMed ID: 30824445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The susceptibility of Pseudomonas aeruginosa strains from cystic fibrosis patients to bacteriophages.
    Essoh C; Blouin Y; Loukou G; Cablanmian A; Lathro S; Kutter E; Thien HV; Vergnaud G; Pourcel C
    PLoS One; 2013; 8(4):e60575. PubMed ID: 23637754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing bacteriophage treatment of resistant
    Ulrich L; Steiner LX; Giez C; Lachnit T
    mSphere; 2024 Jul; 9(7):e0070723. PubMed ID: 38934592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lytic activity by temperate phages of Pseudomonas aeruginosa in long-term cystic fibrosis chronic lung infections.
    James CE; Davies EV; Fothergill JL; Walshaw MJ; Beale CM; Brockhurst MA; Winstanley C
    ISME J; 2015 Jun; 9(6):1391-8. PubMed ID: 25461970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of Pseudomonas aeruginosa veterinary isolates to Pbunavirus PB1-like phages.
    Fujiki J; Furusawa T; Munby M; Kawaguchi C; Matsuda Y; Shiokura Y; Nakamura K; Nakamura T; Sasaki M; Usui M; Iwasaki T; Gondaira S; Higuchi H; Sawa H; Tamura Y; Iwano H
    Microbiol Immunol; 2020 Nov; 64(11):778-782. PubMed ID: 32918505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacteriophage-based therapy in cystic fibrosis-associated Pseudomonas aeruginosa infections: rationale and current status.
    Hraiech S; Brégeon F; Rolain JM
    Drug Des Devel Ther; 2015; 9():3653-63. PubMed ID: 26213462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lytic Bacteriophage Is a Promising Adjunct to Common Antibiotics across Cystic Fibrosis Clinical Strains and Culture Models of
    Martin I; Morales S; Alton EWFW; Davies JC
    Antibiotics (Basel); 2023 Mar; 12(3):. PubMed ID: 36978460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.